Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Barinthus Biotherapeutics (BRNS) Other Non Operating Income (2020 - 2025)

Barinthus Biotherapeutics (BRNS) has disclosed Other Non Operating Income for 6 consecutive years, with -$275000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non Operating Income fell 1157.69% year-over-year to -$275000.0, compared with a TTM value of $209000.0 through Sep 2025, down 74.51%, and an annual FY2024 reading of $135000.0, down 87.52% over the prior year.
  • Other Non Operating Income was -$275000.0 for Q3 2025 at Barinthus Biotherapeutics, down from $320000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $13.8 million in Q1 2022 and bottomed at -$19.8 million in Q2 2021.
  • Average Other Non Operating Income over 5 years is $146615.4, with a median of $89000.0 recorded in 2024.
  • Peak annual rise in Other Non Operating Income hit 1500.0% in 2025, while the deepest fall reached 1157.69% in 2025.
  • Year by year, Other Non Operating Income stood at -$19.8 million in 2021, then surged by 102.61% to $516000.0 in 2022, then soared by 50.0% to $774000.0 in 2023, then crashed by 88.5% to $89000.0 in 2024, then crashed by 408.99% to -$275000.0 in 2025.
  • Business Quant data shows Other Non Operating Income for BRNS at -$275000.0 in Q3 2025, $320000.0 in Q2 2025, and $75000.0 in Q1 2025.